Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis.
What is the true clinicopathologic spectrum of neuromyelitis optica?
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation.
Association of SNPs of CD40 Gene with Multiple Sclerosis in Russians.
Botulinum Toxin-What Urologic Uses Does the Data Support?
Nutrition and Lifestyle Intervention on Mood and Neurological Disorders.
Patient with Neuromyelitis Optica Spectrum Disorder Combined with Sjögren's Syndrome Relapse Free Following Tacrolimus Treatment.
Resilience, self-efficacy, coping styles and depressive and anxiety symptoms in those newly diagnosed with multiple sclerosis.
VLA4 Gene Polymorphism and Susceptibility to Multiple Sclerosis in Slovaks.
NDRG2 promoted secreted miR-375 in microvesicles shed from M1 microglia, which induced neuron damage.
Change of Th17 Lymphocytes and Treg/Th17 in Typical and Atypical Optic Neuritis.
The effect of group psycho-education program on the burden of family caregivers with multiple sclerosis patients in Isfahan in 2013-2014.
Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit.
No evidence for a role of rare CYP27B1 variants in Austrian multiple sclerosis patients.
Determinant spreading and the dynamics of the autoimmune T-cell repertoire.
Longitudinally extensive varicella-zoster virus myelitis in a multiple sclerosis patient.
[Impact of physical activity level on alexithymia and coping strategies in an over-40 multiple sclerosis population: A pilot study.]
Proteasome Inhibitors: A New Perspective for Treating Autoimmune Diseases.
Vitamin D supplementation in multiple sclerosis patients in 2012: hype or reality as an adjunctive therapy?
Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13.
Mesenchymal stem cells are mobilized from the bone marrow during inflammation.
Pharmacodynamic Consequences of Administration of VLA-4 Antagonist CDP323 to Multiple Sclerosis Subjects: A Randomized, Double-Blind Phase 1/2 Study.
Balkans syndrome: a potential link between multiple sclerosis and hypervaccination.
Multiple sclerosis lesion segmentation using dictionary learning and sparse coding.
Targeting IL-10 in Auto-immune Diseases.
Pages
« first
‹ previous
…
347
348
349
350
351
352
353
354
355
…
next ›
last »